Featured Speakers

• 

  Rakesh DixitVice President, Global Head Biologics Safety MedImmune

• 

  James ErnstScientist Genentech

• 

  Allan CapiliScientist II Biogen Idec

• 

  Dieter ZopfGlobal Drug Discovery Bayer Schering Pharma AG

The World’s Largest Bispecific Antibody Meeting

Following the ground-breaking, sell out 2011 World Bispecific Antibody Summit, the next instalment will again bring together the most prominent scientific pioneers and business leaders to drive this revolutionary field forward.

The 3^rd Annual World Bispecific Antibody Summit is the world’s only dedicated meeting where you can meet everyone working on bispecifics in one place. With the latest industry case studies and clinical results; this is the only meeting where you can access the most up-to-date information from some of the world’s biggest players.

With an extended 3 day program, 27 expert speakers, 3 pre-conference workshops and over 10 hours of built in networking sessions; this meeting is the world’s largest bispecific meeting. Whether you have a candidate entering the clinic, you’re working on a platform technology or your company is developing a strategy to move into this space; this is your chance to fully understand the bispecific developmental landscape.

“I think that this meeting is a must for anyone working in the field of bispecific antibodies, basically if you want all the experts under the one roof then this is the place to come to.”
Merrimack Pharmaceuticals 

With leading speakers from the world’s largest pharma including Abbott, Biogen Idec, Genentech, Abbott, Sanofi, Merck, Pfizer and many more, the agenda covers all of the latest advances in bispecific antibody development.

Don’t miss your chance to attend the world’s largest bispecific antibody meeting and meet everyone investing in this field to fully understand the therapeutic opportunities for these superior antibodies. Discover how to tackle the most common challenges facing scientists designing and developing “best in class” bispecifics as well as evaluating the most promising platforms.

Read our fantastic feedback from last year

This year we are covering all aspects of bispecific development, from every perspective in the industry.

Attend the meeting to:

• Hear from Roche on their preclinical evaluation of bispecific targets for rheumatoid arthritis and learn from their selection strategies to deliver lead antibody candidates
•  Learn from Bayer’s methods of constructing small bispecific Fab libraries to identify different types of antibodies for your disease indication
• Discover how Amgen are constructing and expressing bispecific antibodies in several different formats and explore the biochemical and biological properties of bispecifics with Immunomedics
• Get an update on the latest results from Genentech’s platform for penetrating the blood brain barrier with a bispecific molecule
• Learn from leading cancer institutes  on the best ways to extend bispecific half life and  improve cancer imaging and therapy with case studies from Garden State Cancer Center, Tufts Center for the Study of Drug Development and Aaron Diamond AIDS Research Center

Why attend 3^rd Annual World Bispecific Antibody Summit?

• Understand the developmental landscape for the field of bispecifics and benchmark your company against the leaders in the field
• Expand your knowledge of the field with the latest industry case studies on emerging strategies and technologies, bispecific applications and promising clinical results
• Evaluate the most promising bispecific platforms available to the industry and explore the  latest advances in bispecific technologies

How can you get involved?

1. Firstly, let us know if you’ve got material that you’re interested in presenting as there are opportunities to present a poster or sponsor
2. Why not join our community on LinkedIn and join over 1000 of you peers - start discussions, find answers and make new contacts. Simply search groups for Bispecific Antibody Forum
3. Secure your place early and take advantage of the early registration discounts.  Our 2011 meeting sold out so don’t be disappointed